Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
Dabigatran is an oral thrombin inhibitor which has been approved in several countries as an alternative to vitamin-K-antagonists for the prevention of stroke or embolism in atrial fibrillation patients. Dabigatran is introduced into clinical practice, although many issues regarding this drug are sti...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2012-02-01
|
| Colecção: | Pharmaceuticals |
| Assuntos: | |
| Acesso em linha: | http://www.mdpi.com/1424-8247/5/2/155/ |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|